It was always hard to see Sydney deal maker and Everblu Capital Adam Blumenthal continuing to also chair pot stock Creso Pharma after he and Everblu were raided by ASIC. Particularly after Creso informed the bourse on Thursday that it had three days earlier been approached by ASIC to produce documents relating to said investigation.
Lucky for Creso, it had Dr James Ellingford in the wings.
Loading...
Myriam Robin is a senior writer based in the Melbourne newsroom. She has previously been a Rear Window columnist and editor, and before that reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
